Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.
about
The impact of environmental factors in severe psychiatric disorders.Systems psychopharmacology: A network approach to developing novel therapiesPostmortem evidence of cerebral inflammation in schizophrenia: a systematic reviewTranscriptome sequencing of the choroid plexus in schizophreniaGene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia.The Application of Multiplex Biomarker Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Application of Proteomic Techniques for Improved Stratification and Treatment of Schizophrenia Patients.Engram formation in psychiatric disorders.Genome-wide association analyses of child genotype effects and parent-of-origin effects in specific language impairment.Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysisDNA methylation differences in monozygotic twin pairs discordant for schizophrenia identifies psychosis related genes and networks.The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.Schizophrenia: from epidemiology to rehabilitation.Immune system gene dysregulation in autism and schizophrenia.Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.Proteomic profiling in schizophrenia: enabling stratification for more effective treatment.Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study.Finding the needle in the haystack: a review of microarray gene expression research into schizophrenia.Coupling physical exercise with dietary glucose supplement for treating cognitive impairment in schizophrenia: a theoretical model and future directions.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.Clozapine as a Model for Antipsychotic Development.Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.Gene expression in superior temporal cortex of schizophrenia patients.Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication.What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis?Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin.
P2860
Q21129355-1C8CD318-0E30-4239-9263-C325AA65CBD8Q26750901-BF5F322F-16D7-46CB-B0A0-0AB48407EFD0Q28077391-3BDFB50E-7372-442B-8E99-3DB97DA519DFQ30363952-A5A04EF3-0419-47A1-9518-ACF9C0F6FCA5Q30447546-49685397-4D62-4350-BA0B-C39F45BF074CQ33451672-35A50FF4-D8DA-4486-812A-98E8B81833A7Q33453744-17E2DFC0-6309-4695-9306-1A1C3D490C68Q33676492-501E9E04-462E-451B-A3AC-DD98F8191D2FQ33967213-C70CD893-8E7D-49A2-B9A2-8874F7ADFF60Q34458640-D729C85E-24BE-42AE-AC72-617E9BDC491AQ35622570-89091170-DC67-4BE9-BEA2-7CF9CAD8AEB7Q35632339-E0A8AAFE-2109-4B1D-B56C-B3937B987248Q36210656-0F52FF8D-425D-45BB-A7EA-C5BE951BF4D3Q36213513-CD89F51F-F4A1-46F5-93CC-424CCAB6A841Q36297838-35A9A93D-CE06-4605-9FE6-5904A76C1DDEQ36998471-B15585A0-9D5C-4114-9245-CA55A801E32EQ37486473-4B5EFB77-61D7-42FC-8BBE-3360E292E885Q37996281-E4C3B7C4-0CE2-4C69-BB1B-CE31C642CF4EQ38162296-5F045E18-0785-45D2-A765-71ACE3B7D487Q38805367-2CDC451D-2149-4D63-B257-403AF38A2A52Q39227633-C3322660-5A2E-46FF-875E-CF23E7762BE3Q39400094-B419FD44-1DFD-4198-8AEC-573DDD87940CQ42677054-E1C674B4-5D6E-4F08-A3D0-BA2262759CE6Q44176554-2736853A-C383-404D-BB53-0ADDCA7F65D5Q44401758-D3A8827A-2D01-440E-9213-EAA65A73A5C9Q48569172-4E32C219-9D11-4924-A33C-956A33C1E810Q55215406-0DB425CF-496D-4A08-922F-45796AF75498
P2860
Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Regulation of immune-modulator ...... genome-wide microarray study.
@en
Regulation of immune-modulator ...... genome-wide microarray study.
@nl
type
label
Regulation of immune-modulator ...... genome-wide microarray study.
@en
Regulation of immune-modulator ...... genome-wide microarray study.
@nl
prefLabel
Regulation of immune-modulator ...... genome-wide microarray study.
@en
Regulation of immune-modulator ...... genome-wide microarray study.
@nl
P2093
P2860
P50
P1476
Regulation of immune-modulator ...... genome-wide microarray study.
@en
P2093
Eleni Parlapani
Fernando Leonardi-Essmann
Hans Kretzschmar
Mario Herrera-Marschitz
Oliver Gruber
Pascal F Durrenberger
Peter J Gebicke-Haerter
Rainer Spanagel
Richard Reynolds
Thomas Arzberger
P2860
P304
P356
10.3109/15622975.2010.530690
P577
2010-11-22T00:00:00Z